ATXI (Avenue Therapeutics) Price-to-Operating-Cash-Flow : (As of Jan. 18, 2025)

Avenue Therapeutics Price-to-Operating-Cash-Flow Chart

Avenue Therapeutics Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Price-to-Operating-Cash-Flow		Get a 7-Day Free Trial				-	-	-	-	-

Avenue Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Avenue Therapeutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Avenue Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avenue Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avenue Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Avenue Therapeutics's Price-to-Operating-Cash-Flow falls into.

Avenue Therapeutics Price-to-Operating-Cash-Flow Calculation

Avenue Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Avenue Therapeutics's Share Price of today is $1.85.
Avenue Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-16.19.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Avenue Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Avenue Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Avenue Therapeutics Business Description